Real-Time PCR (qPCR) Market by product (Real-Time PCR (qPCR) Systems, Reagents and Assays, Real-Time PCR (qPCR) Consumables)
Industry: Healthcare
Published Date: February-2023
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 204
Report ID: PMRREP31513
The Global revenue from the Real Time PCR qPCR Market was around US$ 3.4 Billion in 2022, with the global market expected to grow at a CAGR of 7.7% to reach a valuation of around US$ 7.8 Billion by the end of 2033.
|
Market Size (2023) |
US$ 3.7 Billion |
|
Projected Market Value (2033) |
US$ 7.8 Billion |
|
Global Market Growth Rate (2023 to 2033) |
7.7% CAGR |
|
Market Share of Top 5 Countries |
56.8% |
As assessed by Persistence Market Research, research segment held a market share of around 59.5% in the global market, in 2022. Overall, real time PCR qPCR market sales account for around 8.8% of revenue share in the global polymerase chain reaction market, which was valued at around US$ 38.7 Billion in 2022.
The global market recorded a historic CAGR of 7.8% in the last 7 years from 2015 to 2022.
An increased use of biomarkers in disease diagnosis using a real-time PCR, it is possible to carry out the growing use of biomarker profiling for disease diagnosis, prognosis, and monitoring of the response to medication.
Real-time PCR technique is expected to become increasingly popular as a result of scientists' and researchers’ efforts to discover novel genes, gene expression, and genetic variation in an organism's tissues. This has enabled them to compare diseased and healthy tissues side by side.
Furthermore, real-time PCR techniques are frequently employed in research facilities to detect mutant genes or to quantify the amount of gene copy number in transformed cell lines. Additionally, the tools and techniques used to measure the amplification products, which keeps getting more advanced by time. As a result, the market will grow exponentially during the forecast period.
The measurement of gene expression is logistically challenging and complex due to the lack of infrastructure in many nations. The real-time PCR technology that uses fluorogenic primers and fluorescence resonance energy transfer (FRET) is more efficient and faster than traditional PCR, as a result, in future emerging nations will utilize real time PCR techniques for various application such as disease diagnosis, ultimately leading to market growth.
The global market is likely to show high growth over the coming years at a CAGR of 7.7% and reach a global market size of US$ 7.8 Billion by 2033.
“Shift from Plant-Based Medications to Genetically-Delivered”
The application of genome analysis techniques in the diagnosis of many infectious diseases, including malaria, HIV, hepatitis, and genetic disorders, has grown in popularity over time.
In order to increase their regional presence and provide their products to new customers, a number of domestic players that offer real-time PCRs have collaborated with leading players to form exclusive distribution agreements. Additionally, this has proven to be a successful strategy for both sides because distribution partners frequently have flexibility in determining product pricing and pay royalties to the innovator company in return for marketing and distributing their products through their strong network.
During the forecast period, the market is expected to develop at a faster rate due to increasing market penetration in emerging nations and a shift in consumer perceptions from plant-delivered drugs to genome-based drugs. Additionally, it is anticipated that the transition from plant-based to genome-based drug development and discoveries will create opportunities for the real time PCR qPCR market to expand in the years to come.
In addition, the demand for real-time PCR technologies to detect the presence of pathogens and microbes is growing as more people are suffering from foodborne illness. Real-time PCR systems are also being adopted by food and beverage manufacturers due to escalating food security concerns and stricter food safety regulations.
“High Cost Associated with Real Time PCR and Availability of Substitute Products”
Several scientific technologies, including nanofabrication and microfluidics, are integrated to provide the desired process output in a unique PCR analysis carried out by real-time PCR systems. Additionally, the development of such devices calls for a sizable capital investment and in-depth nanoscale-level scientific support. As a result, real-time PCR systems are more expensive (about USD 50,000) than conventional PCR equipment.
The development of alternative technologies that can produce results more quickly than real-time PCR, often in less than 30 minutes, such as next-generation sequencing and isothermal PCRs, is anticipated to restrain the growth of the real-time PCR market.
Why is the United States Market Booming?
“Presence of Key Players”
The United States accounted for around 32.2% market share in the global market in 2022.
Due in large part to the existence of favorable regulations and other initiatives about the development of healthcare infrastructure taken by the government, the United States is likely to maintain its leading position during the forecast period. Additionally, the United States market is anticipated to be driven by the substantial presence of prominent manufacturers and the growing need for rapid diagnostic tests in the country during the course of the projected period.
Will the Germany Be a Lucrative Market for Real Time PCR qPCR?
“Strong Research and Development Scenario”
The Germany market held around 6.8% market share of the global market in 2022.
The market for real-time PCR is anticipated to be driven by Germany's intensive research and development efforts in creating novel medications for the treatment of cancer. One such way for treating cancer is gene therapy.
In monogenic disorders, gene therapy can be used to restore cell function. It can also give cells new abilities, such as enhanced cancer cell killing, the expression of genes that cause suicide to control the elimination of cell populations, or resistance to viral infections.
Thus, the strong research and development activities in providing novel treatments for various chronic diseases will create high demands for the RT-PCR market.
How is China Emerging as a Prominent Market?
“Market Penetration by International Players”
China held a market share of about 7.3% of the global market in 2022.
The country's untapped potential, considerable unmet clinical needs, and rising healthcare expenditures are encouraging international players to penetrate the market. Real time PCR applications are also anticipated to be in demand throughout the forecast period as a result of technical advancements and the rising prevalence of many target diseases. In addition, it is projected that the local players' product launches in the market will boost market growth.
Why are Real Time PCR Reagents and Assays Highly Sought After?
“Widespread Use in Research and Academic Institutions”
The reagents and assays segment held around 42.8% share of the total market in 2022.
An increase in the need for early disease diagnosis as well as the number of players manufacturing and marketing reagents and assays. The significant segment share is further supported by the widespread use of reagents and assays as well as the rising demand for research, academic, and other uses.
Furthermore, there is a greater need for reagents and assays as a result of the rising prevalence of chronic diseases and the expanding usage of PCR. Additionally, the growing acceptance of technological breakthroughs in the pharmaceutical and healthcare sectors as well as enhanced research and development will create the promising prospects for to further grow in the future.
Which Application Segment is Dominant Within the Global Market?
“Growing Research Efforts in Developing Medications for Various Diseases”
Research segment held around 59.5% share of the total market in 2022.
A few of the factors influencing the segment's growth are the rising prevalence of diseases like cancer, infectious diseases, and diabetes, the development of high precision testing methods, the rising demand for reagents for diagnostics, research, and academic purposes, and the effective disease diagnosis, monitoring, and treatment.
Which End User Segment Will Emerge as Key Contributor?
“Widespread Utilization of PCR Techniques in Various Projects”
Academic and research institutes segment held around 25.0% share of the total market in 2022.
PCR-based techniques have fueled major scientific endeavors like the human genome project. Researchers frequently utilize this method to quickly and accurately detect diseases, clone and sequence genes, and execute complex quantitative and genomic analyses. Additionally, academic institutions make significant efforts to perform numerous life science research and experiments for education purposes.
The market is quite competitive due to the numerous regional and international players. Companies are expected to keep their market share through the presence of a robust product range and rising investment in R&D operations.
Some key instances of development include:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the real time PCR qPCR market, which are available in the full report.
|
Attribute |
Details |
|
Forecast Period |
2023 to 2033 |
|
Historical Data Available for |
2015 to 2022 |
|
Market Analysis |
USD Million for Value |
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Product:
Application:
End User:
Region:
To know more about delivery timeline for this report Contact Sales
The global market is currently valued at around US$ 3.4 Billion in 2022.
The global market will reach a valuation of around US$ 3.7 billion by the end of 2023.
Sales of the market are set to witness growth at a CAGR of 7.7% and be valued at around US$ 7.8 Billion by 2033.
Demand for the global market increased at a 7.8% CAGR from 2015 to 2022.
The U.S., China, Germany, Japan, and France account for most demand within the market, currently holding around 56.8% market share.
The U.S. accounts for around 32.2% share of the global market in 2022.
The China market held a share of about 7.3% in the global real time PCR qPCR market in 2022.
The German real time PCR qPCR market is set to expand at 8.2% CAGR over the forecast period.
Medtronic plc, Boston Scientific Corporation, Abbott, and Hoffman-La Roche areealthcarehhhhh among others are the key players in the global market.
An increasing adoption of scientific disciplines such as forensic science, human genetic testing, growing use of PCR techniques in drug development and increasing numbers of biotechnology and pharmaceutical industries are few of the factors propelling the global market.
